In 2024, Medipal Holdings completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Medipal Holdings has also provided a category-level breakdown for 8 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021-2019 |
|---|---|---|---|---|
Total Scope 1 | 31,081a | 28,439a | 30,700a | |
Total Scope 2 | ||||
Unspecified Calculation Method | 42,494a | 46,552a | 46,996a | |
Total Scope 3 | 219,650a | 228,773a | 38,884b | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 1.3226a | 1.1274a | 1.1383a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2024, the total operational greenhouse gas (GHG) emissions of Medipal Holdings amounted to 73,575 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Medipal Holdings decreased by 1.89%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2024, the total Scope 1 emissions of Medipal Holdings were 31,081 metric tons of CO₂ equivalent (tCO₂e).a
Since 2019, Medipal Holdings's Scope 1 emissions have decreased by 12.21%, reflecting a declining long-term trend in Scope 1 emissions over time.ab
Compared to the previous year (2023), Medipal Holdings's Scope 1 emissions increased by 9.29%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.a
In 2024, Medipal Holdings reported Scope 2 greenhouse gas (GHG) emissions of 42,494 tCO₂e without specifying the calculation method.a
Since 2019, Medipal Holdings's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 19.19%, reflecting a declining long-term trend in Scope 2 emissions over time.ab
Compared to the previous year (2023), Medipal Holdings's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Medipal Holdings's emissions have plateaued with no significant change in its energy consumption footprint.a
In 2024, Medipal Holdings reported its Scope 2 emissions using an unspecified methodology.a
In 2024, Medipal Holdings reported 219,650 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of Medipal Holdings includes a breakdown across 8 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in 2023, reflecting improved emissions accounting practices and greater transparency across the company's value chaina
In 2024, Medipal Holdings reported total Scope 3 emissions of 219,650 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 91.42% of these emissions originated from upstream activities such as purchased goods and capital goods, while 8.58% came from downstream activities like product use, distribution, and end-of-life treatment.a
Since 2019, Medipal Holdings's Scope 3 emissions have increased by 543.66%, reflecting a rising long-term trend in Scope 3 emissions over time.ab
Compared to the previous year (2023), Medipal Holdings's Scope 3 emissions remained relatively stable, indicating that Medipal Holdings's emissions have plateaued with no significant change in its value chain footprint.a
In 2024, Medipal Holdings reported emissions for 8 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This partial disclosure allows for some insight into the company's indirect impacts.
In 2024, the largest contributors to Medipal Holdings's Scope 3 emissions were:a
In 2024, Medipal Holdings reported Scope 1 greenhouse gas (GHG) emissions of 31,081 tCO₂e and total revenues of USD 23,500 millions. This translates into an emissions intensity of 1.32 tCO₂e per millions USD.a
In 2024, Medipal Holdings reported a Scope 1 emissions intensity of 1.32 tCO₂e per millions USD. Compared to the peer group median of 0.73, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a
In 2024, Medipal Holdings ranked 13 out of 22 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
Medipal Holdings is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a
In 2024, Medipal Holdings reported a total carbon footprint of 293,225 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 3.47% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output.a
The largest contributor to Medipal Holdings's total carbon footprint was Scope 3 emissions, accounting for 74.91% of the company's total carbon footprint, followed by Scope 2 emissions at 14.49%.a